Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Equivalence of Vi-DT Multi-dose vs Single-dose
NCT04204096Phase 3Completed
- Sponsor
- International Vaccine Institute
- Start
- Feb 2020
- Primary completion
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Typhoid conjugate vaccine Vi-DT in typhoid fever, sponsored by International Vaccine Institute. Started Feb 2020; status: completed.
02
Drugs
Typhoid conjugate vaccine Vi-DT
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT04204096.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04204096.